Treatment to extend lives of ALS patients expected soon

Thanks! Share it with your friends!

You disliked this video. Thanks for the feedback!

Published Oct 5, 2022

The FDA approved Relyvrio Thursday with the goal of slowing down the deadly degenerative disease, ALS.

Be the first to comment